On the role of prolyl oligopeptidase in health and disease

Neuropeptides

Volumn 41, Issue 1, 2007, Pages 1-24

  Garcia Horsman J A ^a   Mannisto P T ^b,c   Venalainen J I ^b  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Arginine vasopressin; Gonadoliberin; Inositol cycle; Memory and learning; Neuropeptide metabolism; Prolyl oligopeptidase; Substance P; Thyroliberin

Indexed keywords

ALPHA INTERMEDIN; ANGIOTENSIN DERIVATIVE; ARGIPRESSIN; BETA ENDORPHIN; BRADYKININ; GONADORELIN; NEUROPEPTIDE; NEUROTENSIN; OXYTOCIN; PROLYL ENDOPEPTIDASE; PROTIRELIN; SUBSTANCE P;

ARTICLE; BRAIN MEMBRANE; CATALYSIS; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SUBSTRATE; EVALUATION; GENE EXPRESSION; GENE LOCATION; HUMAN; MEDICAL RESEARCH; MOLECULAR RECOGNITION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; SERUM;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; OLIGOPEPTIDES; PROLINE; PROTEIN CONFORMATION; REFERENCE VALUES;

EID: 33846203261     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2006.10.004     Document Type: Article

References (244)

1. Abbas A., Gorelik G., Carbini L.A., and Scicli A.G. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension 30 (1997) 217-221
2. Advis J.P., Krause J.E., and McKelvy J.F. Luteinizing hormone-releasing hormone peptidase activities in discrete hypothalamic regions and anterior pituitary of the rat: apparent regulation during the prepubertal period and first estrous cycle at puberty. Endocrinology 110 (1982) 1238-1245
3. Agirregoitia N., Irazusta A., Ruiz F., Irazusta J., and Gil J. Ontogeny of soluble and particulate prolyl endopeptidase activity in several areas of the rat brain and in the pituitary gland. Dev. Neurosci. 25 (2003) 316-323
4. Agirregoitia N., Gil J., Ruiz F., Irazusta J., and Casis L. Effect of aging on rat tissue peptidase activities. J. Gerontol. A: Biol. Sci. Med. Sci. 58 9 (2003) B792-B797
5. Aoyagi T., Wada T., Nagai M., Kojima F., Harada S., Takeuchi T., Takahashi H., Hirokawa K., and Tsumita T. Increased gamma-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease. Chem. Pharm. Bull. (Tokyo) 38 (1990) 1748-1749
6. Aoyagi T., Wada T., Nagai M., Kojima F., Harada S., Takeuchi T., Takahashi H., Hirokawa K., and Tsumita T. Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer's disease. Experientia 46 (1990) 94-97
7. Ariga N., Sato E., Ohuchi N., Nagura H., and Ohtani H. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int. J. Cancer 95 (2001) 67-72
8. Atack J.R., Suman-Chauhan N., Dawson G., and Kulagowski J.J. In vitro and in vivo inhibition of prolyl endopeptidase. Eur. J. Pharmacol. 205 (1991) 157-163
9. Bakker A.V., Jung S., Spencer R.W., Vinick F.J., and Faraci W.S. Slow tight-binding inhibition of prolyl endopeptidase by benzyloxycarbonyl-prolyl-prolinal. Biochem. J. 271 (1990) 559-562
10. Bar J.W., Rahfeld J.U., Schulz I., Gans K., Ruiz-Carrillo D., Manhart S., Rosche F., and Demuth H.U. Prolyl endopeptidase cleaves the apoptosis rescue peptide humanin and exhibits an unknown post-cysteine cleavage specificity. Adv. Exp. Med. Biol. 575 (2006) 103-108
11. Barelli H., Ahmad S., Kostka P., Fox J.A., Daniel E.E., Vincent J.P., and Checler F. Neuropeptide-hydrolysing activities in synaptosomal fractions from dog ileum myenteric, deep muscular and submucous plexi. Their participation in neurotensin inactivation. Peptides 10 (1989) 1055-1061
12. Barelli H., Petit A., Hirsch E., Wilk S., De Nanteuil G., Morain P., and Checler F. S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase. Biochem. Biophys. Res. Commun. 257 (1999) 657-661
13. Beal M.F., and Mazurek M.F. Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. Neurology 37 (1987) 1205-1209
14. Beal M.F., Kowall N.W., and Mazurek M.F. Neuropeptides in Alzheimer's disease. J. Neural. Transm. Suppl 24 (1987) 163-174
15. Bellemere G., Morain P., Vaudry H., and Jegou S. Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocyte-stimulating hormone breakdown in the rat brain. J. Neurochem. 84 (2003) 919-929
16. Bellemere G., Vaudry H., Mounien L., Boutelet I., and Jegou S. Localization of the mRNA encoding prolyl endopeptidase in the rat brain and pituitary. J. Comp. Neurol. 471 (2004) 128-143
17. Bellemere G., Vaudry H., Morain P., and Jegou S. Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain. J. Neuroendocrinol. 17 (2005) 306-313
18. Benzing W.C., Mufson E.J., Jennes L., and Armstrong D.M. Reduction of neurotensin immunoreactivity in the amygdala in Alzheimer's disease. Brain Res. 537 (1990) 298-302
19. Berridge M.J., Downes C.P., and Hanley M.R. Neural and developmental actions of lithium: a unifying hypothesis. Cell 59 (1989) 411-419
20. Berry M.D., and Boulton A.A. Apoptosis and human neurodegenerative diseases. Prog. Neuropsychopharmacol. Biol. Psych. 27 (2003) 197-198
21. Birney Y.A., and O'Connor B.F. Purification and characterization of a Z-pro-prolinal-insensitive Z-Gly-Pro-7-amino-4-methyl coumarin-hydrolyzing peptidase from bovine serum - a new proline-specific peptidase. Protein. Expr. Purif. 22 (2001) 286-298
22. Boettger A., Kertscher U., Steinmann C., Baeger U., Siems W.E., and Heder G. Degradation of bradykinin in semen of ram and boar. Biochem. Pharmacol. 45 (1993) 1983-1988
23. Brandt I., De Vriendt K., Devreese B., Van Beeumen J., Van Dongen W., Augustyns K., De Meester I., Scharpe S., and Lambeir A.M. Search for substrates for prolyl oligopeptidase in porcine brain. Peptides 26 (2005) 2536-2546
24. Breen G., Harwood A.J., Gregory K., Sinclair M., Collier D., St Clair D., and Williams R.S. Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients. Bipolar. Disord. 6 (2004) 156-161
25. Camargo A.C., Caldo H., and Emson P.C. Degradation of neurotensin by rabbit brain endo-oligopeptidase A and endo-oligopeptidase B (proline-endopeptidase). Biochem. Biophys. Res. Commun. 116 (1983) 1151-1159
26. Casarini D.E., Boim M.A., Stella R.C., and Schor N. Endopeptidases (kininases) are able to hydrolyze kinins in tubular fluid along the rat nephron. Am. J. Physiol. 277 (1999) F66-F74
27. Cavasin M.A., Rhaleb N.E., Yang X.P., and Carretero O.A. Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP. Hypertension 43 (2004) 1140-1145
28. Chappell M.C., Iyer S.N., Diz D.I., and Ferrario C.M. Antihypertensive effects of angiotensin-(1-7). Braz. J. Med. Biol. Res. 31 (1998) 1205-1212
29. Checler F., Emson P.C., Vincent J.P., and Kitabgi P. Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase. J. Neurochem. 43 (1984) 1295-1301
30. Checler F., Amar S., Kitabgi P., and Vincent J.P. Catabolism of neurotensin by neural (neuroblastoma clone N1E115) and extraneural (HT29) cell lines. Peptides 7 (1986) 1071-1077
31. Chen W.T., and Kelly T. Seprase complexes in cellular invasiveness. Cancer. Metastasis. Rev. 22 (2003) 259-269
32. Cheng L., Lumb M., Polgár L., and Mudge A.W. How can the mood stabilizer VPA limit both mania and depression?. Mol. Cell. Neurosci. 29 (2005) 155-161
33. Chevallier S., Goeltz P., Thibault P., Banville D., and Gagnon J. Characterization of a prolyl endopeptidase from Flavobacterium meningosepticum. Complete sequence and localization of the active-site serine. J. Biol. Chem. 267 (1992) 8192-8199
34. Collins P.J., McMahon G., O'Brien P., and O'Connor B. Purification, identification and characterisation of seprase from bovine serum. Int. J. Biochem. Cell. Biol. 36 (2004) 2320-2333
35. Contijoch A.M., Johnson A.L., and Advis J.P. Norepinephrine-stimulated in vitro release of luteinizing hormone-releasing hormone (LHRH) from median eminence tissue is facilitated by inhibition of LHRH-degrading activity in hens. Biol. Reprod. 42 (1990) 222-230
36. Cumming R.C., Andon N.L., Haynes P.A., Park M., Fischer W.H., and Schubert D. Protein disulfide bond formation in the cytoplasm during oxidative stress. J. Biol. Chem. 279 (2004) 21749-21758
37. Cunningham D.F., and O'Connor B. Identification and initial characterisation of a N-benzyloxycarbonyl-prolyl-prolinal (Z-Pro-prolinal)-insensitive 7-(N-benzyloxycarbonyl-glycyl-prolyl-amido)-4-methylcoumarin (Z-Gly-Pro-NH-Mec)-hydrolysing peptidase in bovine serum. Eur. J. Biochem. 244 (1997) 900-903
38. Cunningham D.F., and O'Connor B. Proline specific peptidases. Biochim. Biophys. Acta. 1343 (1997) 160-186
39. Dalmaz C., Netto C.A., Volkmer N., Dias R., and Izquierdo I. Hypothalamic proline endopeptidase activity is not changed by various behavioral procedures. Brain Res. Bull. 17 (1986) 137-140
40. Dalmaz C., Netto C.A., Volkmer N., Dias R.D., and Izquierdo I. Distribution of proline endopeptidase activity in sub-synaptosomal fractions of rat hypothalamus. Braz. J. Med. Biol. Res. 19 (1986) 685-690
41. Dauch P., Masuo Y., Vincent J.P., and Checler F. A survey of the cerebral regionalization and ontogeny of eight exo- and endopeptidases in murines. Peptides 14 (1993) 593-599
42. Dauch P., Vincent J.P., and Checler F. Molecular cloning and expression of rat brain endopeptidase 3.4.24.16. J. Biol. Chem. 270 (1995) 27266-27271
43. Del Bel E.A., Gambarini A.G., and Martins A.R. Neuropeptide-metabolizing peptidases in neuro-2a neuroblastoma and C6 glioma cells. J. Neurochem. 47 (1986) 938-944
44. Del Bel E.A., Padovan A.P., Padovan G.J., Sellinger O.Z., and Martins A.R. Enzymatic inactivation of bradykinin by rat brain neuronal perikarya. Cell. Mol. Neurobiol. 9 (1989) 379-400
45. De Nanteuil G., Portevin B., and Lepagnol J. Prolyl endopeptidase inhibitors: a new class of memory enhancing drugs. Drug. Future 23 (1998) 167-179
46. Dendorfer A., Vordermark D., and Dominiak P. Degradation of bradykinin by bovine tracheal epithelium and isolated epithelial cells. Br. J. Pharmacol. 120 (1997) 121-129
47. Diosdado B., Wapenaar M.C., Franke L., Duran K.J., Goerres M.J., Hadithi M., Crusius J.B., Meijer J.W., Duggan D.J., Mulder C.J., Holstege F.C., and Wijmenga C. A microarray screen for novel candidate genes in coeliac disease pathogenesis. Gut 53 (2004) 944-951
48. Diosdado B., Stepniak D.T., Monsuur A.J., Franke L., Wapenaar M.C., Mearin M.L., Koning F., and Wijmenga C. No genetic association of the human prolyl endopeptidase gene in the Dutch celiac disease population. Am. J. Physiol. Gastrointest. Liver. Physiol. 289 (2005) G495-G500
49. Dresdner K., Barker L.A., Orlowski M., and Wilk S. Subcellular distribution of prolyl endopeptidase and cation-sensitive neutral endopeptidase in rabbit brain. J. Neurochem. 38 (1982) 1151-1154
50. Faivre-Bauman A., Loudes C., Barret A., Tixier-Vidal A., and Bauer K. Possible role of neuropeptide degrading enzymes on thyroliberin secretion in fetal hypothalamic cultures grown in serum free medium. Neuropeptides 7 (1986) 125-138
51. Ferrario C.M. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 47 (2006) 515-521
52. Ferrario C.M., Trask A.J., and Jessup J.A. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am. J. Physiol. Heart. Circ. Physiol. 289 (2005) H2281-H2290
53. Fruitier-Arnaudin I., Cohen M., Coitoux C., and Piot J.M. In vitro metabolism of LVV-Hemorphin-7 by renal cytosol and purified prolyl endopeptidase. Peptides 24 (2003) 1201-1206
54. Fukunari A., Kato A., Sakai Y., Yoshimoto T., Ishiura S., Suzuki K., and Nakajima T. Colocalization of prolyl endopeptidase and amyloid beta-peptide in brains of senescence-accelerated mouse. Neurosci. Lett. 176 (1994) 201-204
55. Fülöp V., Bocskei Z., and Polgár L. Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis. Cell 94 (1998) 161-170
56. Fülöp V., Szeltner Z., and Polgár L. Catalysis of serine oligopeptidases is controlled by a gating filter mechanism. EMBO Rep. 1 (2000) 277-281
57. Fülöp V., Szeltner Z., Renner V., and Polgár L. Structures of prolyl oligopeptidase substrate/inhibitor complexes. Use of inhibitor binding for titration of the catalytic histidine residue. J. Biol. Chem. 276 (2001) 1262-1266
58. Fuse Y., Polk D.H., Lam R.W., Reviczky A.L., and Fisher D.A. Distribution and ontogeny of thyrotropin-releasing hormone degrading enzymes in rats. Am. J. Physiol. 259 6 Pt 1 (1990) E787-E791
59. Fuxreiter M., Magyar C., Juhasz T., Szeltner Z., Polgár L., and Simon I. Flexibility of prolyl oligopeptidase: molecular dynamics and molecular framework analysis of the potential substrate pathways. Proteins 60 (2005) 504-512
60. García-Horsman, J.A., Venäläinen, J.I., Lohi, O., Auriola, I.S., Korponay-Szabo, I.R., Kaukinen, K., Mäki, M., Männistö, P.T., 2007. Deficient Activity of Mammalian Prolyl Oligopeptidase on the Immunoactive Peptide Digestion in Coeliac Disease. Scand. J. Gastroenterol., doi:10.1080/00365520601019819.
61. Gibson A., Edwardson J., and McDermott J. Post mortem levels of some brain peptidases in Alzheimer's disease: reduction in proline endopeptidase activity in cerebral cortex. Neurosci. Res. Commun. 9 (1991) 73-81
62. Goossens F., De Meester I., Vanhoof G., and Scharpe S. A sensitive method for the assay of serum prolyl endopeptidase. Eur. J. Clin. Chem. Clin. Biochem. 30 (1992) 235-238
63. Goossens F., De Meester I., Vanhoof G., and Scharpe S. Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids. Eur. J. Clin. Chem. Clin. Biochem. 34 (1996) 17-22
64. Goossens F., Wauters J.G., Vanhoof G.C., Bossuyt P.J., Schatteman K.A., Loens K., and Scharpe S.L. Subregional mapping of the human lymphocyte prolyl oligopeptidase gene (PREP) to human chromosome 6q22. Cytogenet. Cell. Genet. 74 (1996) 99-101
65. Goossens F., Vanhoof G., De Meester I., Augustyns K., Borloo M., Tourwe D., Haemers A., and Scharpe S. Development and evaluation of peptide-based prolyl oligopeptidase inhibitors-introduction of N-benzyloxycarbonyl-prolyl-3-fluoropyrrolidine as a lead in inhibitor design. Eur. J. Biochem. 250 (1997) 177-183
66. Greene L.J., Spadaro A.C., Martins A.R., Perussi De Jesus W.D., and Camargo A.C. Brain endo-oligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II. Hypertension 4 (1982) 178-184
67. Grellier P., Vendeville S., Joyeau R., Bastos I.M., Drobecq H., Frappier F., Teixeira A.R., Schrevel J., Davioud-Charvet E., Sergheraert C., and Santana J.M. Trypanosoma cruzi prolyl oligopeptidase Tc80 is involved in nonphagocytic mammalian cell invasion by trypomastigotes. J. Biol. Chem. 276 (2001) 47078-47086
68. Griffiths E.C. Clinical applications of thyrotrophin-releasing hormone. Clin. Sci. (Lond). 73 (1987) 449-457
69. Groth T., Synowitz J., Malsch G., Richau K., Albrecht W., Lange K.P., and Paul D. Contact activation of plasmatic coagulation on polymeric membranes measured by the activity of kallikrein in heparinized plasma. J. Biomater Sci. Polym. Ed. 8 (1997) 797-807
70. Harwood A.J. Neurodevelopment and mood stabilizers. Curr. Mol. Med. 3 (2003) 472-482
71. Harwood A.J., and Agam G. Search for a common mechanism of mood stabilizers. Biochem. Pharmacol. 66 (2003) 179-189
72. Harwood V.J., and Schreier H.J. Prolyl oligopeptidase from Pyrococcus furiosus. Method. Enzymol. 330 (2001) 445-454
73. Harwood V.J., Denson J.D., Robinson-Bidle K.A., and Schreier H.J. Overexpression and characterization of a prolyl endopeptidase from the hyperthermophilic archaeon Pyrococcus furiosus. J. Bacteriol. 179 (1997) 3613-3618
74. Hasenohrl R.U., Souza-Silva M.A., Nikolaus S., Tomaz C., Brandao M.L., Schwarting R.K., and Huston J.P. Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 34 (2000) 272-280
75. Hausch F., Shan L., Santiago N.A., Gray G.M., and Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002) G996-G1003
76. Hausch F., Halttunen T., Maki M., and Khosla C. Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase. Chem. Biol. 10 (2003) 225-231
77. Hebb A.L., Poulin J.F., Roach S.P., Zacharko R.M., and Drolet G. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Prog. Neuropsychopharmacol. Biol. Psych. 29 (2005) 1225-1238
78. Heder G., Bottger A., Siems W.E., Rottmann M., and Kertscher U. The enzymatic degradation of bradykinin in semen of various species. Andrologia 26 (1994) 295-301
79. Hersh L.B., and McKelvy J.F. Enzymes involved in the degradation of thyrotropin releasing hormone (TRH) and luteinizing hormone releasing hormone (LH-RH) in bovine brain. Brain Res. 168 (1979) 553-564
80. Huston J.P., and Hasenohrl R.U. The role of neuropeptides in learning: focus on the neurokinin substance P. Behav. Brain Res. 66 (1995) 117-127
81. Ichai C., Chevallier N., Delaere P., Dournaud P., Epelbaum J., Hauw J.J., Vincent J.P., and Checler F. Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease. J. Neurochem. 62 (1994) 645-655
82. Irazusta J., Silveira P.F., Gil J., Varona A., and Casis L. Effects of hydrosaline treatments on prolyl endopeptidase activity in rat tissues. Regul. Pept. 101 (2001) 141-147
83. Irazusta J., Larrinaga G., Gonzalez-Maeso J., Gil J., Meana J.J., and Casis L. Distribution of prolyl endopeptidase activities in rat and human brain. Neurochem. Int. 40 (2002) 337-345
84. Ishino T., Ohtsuki S., Homma K., and Natori S. cDNA cloning of mouse prolyl endopeptidase and its involvement in DNA synthesis by Swiss 3T3 cells. J. Biochem. (Tokyo) 123 (1998) 540-545
85. Ishitani R., Tanaka M., Sunaga K., Katsube N., and Chuang D.M. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol. Pharmacol. 53 (1998) 701-707
86. Ishiura S., Nishikawa T., Tsukahara T., Momoi T., Ito H., Suzuki K., and Sugita H. Distribution of Alzheimer's disease amyloid A4-generating enzymes in rat brain tissue. Neurosci. Lett. 115 (1990) 329-334
87. IUBMB. Enzyme Nomenclature 1992 (1992), International Union of Biochemistry and Molecular Biology, San Diego
88. Jaeken J., Martens K., Francois I., Eyskens F., Lecointre C., Derua R., Meulemans S., Slootstra J.W., Waelkens E., de Zegher F., Creemers J.W., and Matthijs G. Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome. Am. J. Hum. Genet. 78 (2006) 38-51
89. Jarho E.M., Venäläinen J.I., Huuskonen J., Christiaans J.A., García-Horsman J.A., Forsberg M.M., Jarvinen T., Gynther J., Männistö P.T., and Wallén E.A. A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors. J. Med. Chem. 47 (2004) 5605-5607
90. Jarho E.M., Wallén E.A., Christiaans J.A., Forsberg M.M., Venäläinen J.I., Männistö P.T., Gynther J., and Poso A. Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions. J. Med. Chem. 48 (2005) 4772-4782
91. Jiang C.H., Tsien J.Z., Schultz P.G., and Hu Y. The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc. Natl. Acad. Sci. USA 98 (2001) 1930-1934
92. Kabashima T., Fujii M., Meng Y., Ito K., and Yoshimoto T. Prolyl endopeptidase from Sphingomonas capsulata: isolation and characterization of the enzyme and nucleotide sequence of the gene. Arch. Biochem. Biophys. 358 (1998) 141-148
93. Kahyaoglu A., Haghjoo K., Guo F., Jordan F., Kettner C., Felfoldi F., and Polgár L. Low barrier hydrogen bond is absent in the catalytic triads in the ground state but Is present in a transition-state complex in the prolyl oligopeptidase family of serine proteases. J. Biol. Chem. 272 (1997) 25547-25554
94. Kaneko T., Wood G., Crouch W.L., and Desiderio D.M. Substance P inactivating enzymes in human cerebrospinal fluid. Peptides 15 (1994) 41-47
95. Kaspari A., Diefenthal T., Grosche G., Schierhorn A., and Demuth H.U. Substrates containing phosphorylated residues adjacent to proline decrease the cleavage by proline-specific peptidases. Biochim. Biophys. Acta. 1293 (1996) 147-153
96. Kato T., Nakano T., Kojima K., Nagatsu T., and Sakakibara S. Changes in prolyl endopeptidase during maturation of rat brain and hydrolysis of substance P by the purified enzyme. J. Neurochem. 35 (1980) 527-535
97. Kato T., Okada M., and Nagatsu T. Distribution of post-proline cleaving enzyme in human brain and the peripheral tissues. Mol. Cell. Biochem. 32 (1980) 117-121
98. Katsube N., Sunaga K., Chuang D.M., and Ishitani R. ONO-1603, a potential antidementia drug, shows neuroprotective effects and increases m3-muscarinic receptor mRNA levels in differentiating rat cerebellar granule neurons. Neurosci. Lett. 214 (1996) 151-154
99. Kikkawa F., Kajiyama H., Ino K., Watanabe Y., Ito M., Nomura S., Itakura A., Tsujimoto M., and Mizutani S. Possible involvement of placental peptidases that degrade gonadotropin-releasing hormone (GnRH) in the dynamic pattern of placental hCG secretion via GnRH degradation. Placenta 23 (2002) 483-489
100. Kimura A., Ohnishi J., Okimura H., Hamabata T., and Takahashi T. Localization of prolyl endopeptidase mRNA in small growing follicles of porcine ovary. Mol. Reprod. Dev. 50 (1998) 121-127
101. Kimura A., Yoshida I., Takagi N., and Takahashi T. Structure and localization of the mouse prolyl oligopeptidase gene. J. Biol. Chem. 274 (1999) 24047-24053
102. Kimura A., Matsui H., and Takahashi T. Expression and localization of prolyl oligopeptidase in mouse testis and its possible involvement in sperm motility. Zool. Sci. 19 (2002) 93-102
103. Knisatschek H., and Bauer K. Characterization of "thyroliberin-deamidating enzyme" as a post-proline-cleaving enzyme. Partial purification and enzyme-chemical analysis of the enzyme from anterior pituitary tissue. J. Biol. Chem. 254 (1979) 10936-10943
104. Koida M., and Walter R. Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography. J. Biol. Chem. 251 (1976) 7593-7599
105. Kovacs G.L., and De Wied D. Peptidergic modulation of learning and memory processes. Pharmacol. Rev. 46 (1994) 269-291
106. Kusuhara M., Hachisuka H., Nakano S., and Sasai Y. Purification and characterization of prolyl endopeptidase from rat skin. J. Dermatol. Sci. 6 (1993) 138-145
107. Lawrence A.C., Clark I.J., and Campbell D.J. Increased angiotensin-(1-7) in hypophysial-portal plasma of conscious sheep. Neuroendocrinology 55 (1992) 105-114
108. Leprince J., Cosquer D., Bellemere G., Chatenet D., Tollemer H., Jegou S., Tonon M.C., and Vaudry H. Catabolism of the octadecaneuropeptide ODN by prolyl endopeptidase: identification of an unusual cleavage site. Peptides 27 (2006) 1561-1569
109. Levesque M., Parent R., and Parent A. Cellular and subcellular localization of neurokinin-1 and neurokinin-3 receptors in primate globus pallidus. Eur. J. Neurosci. 23 10 (2006) 2760-2772
110. Leung D., Abbenante G., and Fairlie D.P. Protease inhibitors: current status and future prospects. J. Med. Chem. 43 (2000) 305-341
111. Lew R.A., Tetaz T.J., Glucksman M.J., Roberts J.L., and Smith A.I. Evidence for a two-step mechanism of gonadotropin-releasing hormone metabolism by prolyl endopeptidase and metalloendopeptidase EC 3.4.24.15 in ovine hypothalamic extracts. J. Biol. Chem. 269 (1994) 12626-12632
112. Lew R.A., Cowley M., Clarke I.J., and Smith A.I. Peptidases that degrade gonadotropin-releasing hormone: influence on LH secretion in the ewe. J. Neuroendocrinol. 9 (1997) 707-712
113. Li P., Chappell M.C., Ferrario C.M., and Brosnihan K.B. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 29 (1997) 394-400
114. Lima C.V., Paula R.D., Resende F.L., Khosla M.C., and Santos R.A. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension 30 (1997) 542-548
115. Liu Y., Patricelli M.P., and Cravatt B.F. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA 96 (1999) 14694-14699
116. Maes M., Goossens F., Scharpe S., Meltzer H.Y., D'Hondt P., and Cosyns P. Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol. Psych. 35 (1994) 545-552
117. Maes M., Goossens F., Scharpe S., Calabrese J., Desnyder R., and Meltzer H.Y. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiat. Res. 58 (1995) 217-225
118. Maes M., Goossens F., Lin A., De Meester I., Van Gastel A., and Scharpe S. Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety. Psychoneuroendocrinology 23 (1998) 485-495
119. Maes M., Libbrecht I., Van Hunsel F., Lin A.H., Bonaccorso S., Goossens F., De Meester I., De Clerck L., Biondi M., Scharpe S., and Janca A. Lower serum activity of prolyl endopeptidase in fibromyalgia is related to severity of depressive symptoms and pressure hyperalgesia. Psychol. Med. 28 (1998) 957-965
120. Maes M., Lin A., Bonaccorso S., Vandoolaeghe E., Song C., Goossens F., De Meester I., Degroote J., Neels H., Scharpe S., and Janca A. Lower activity of serum peptidases in abstinent alcohol-dependent patients. Alcohol. 17 (1999) 1-6
121. Maes M., Lin A.H., Bonaccorso S., Goossens F., Van Gastel A., Pioli R., Delmeire L., and Scharpe S. Higher serum prolyl endopeptidase activity in patients with post-traumatic stress disorder. J. Affect. Disord. 53 (1999) 27-34
122. Maes M., Monteleone P., Bencivenga R., Goossens F., Maj M., van West D., Bosmans E., and Scharpe S. Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa. Psychoneuroendocrinology 26 (2001) 17-26
123. Maes M., Bosmans E., and Ombelet W. In the puerperium, primiparae exhibit higher levels of anxiety and serum peptidase activity and greater immune responses than multiparae. J. Clin. Psychiat. 65 (2004) 71-76
124. Mantle D., Falkous G., Ishiura S., Blanchard P.J., and Perry E.K. Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. Clin. Chim. Acta. 249 (1996) 129-139
125. Martens K., Derua R., Meulemans S., Waelkens E., Jaeken J., Matthijs G., and Creemers J.W. PREPL: a putative novel oligopeptidase propelled into the limelight. Biol. Chem. 387 (2006) 879-883
126. Matsubara Y., Ono T., Tsubuki S., Irie S., and Kawashima S. Transient up-regulation of a prolyl endopeptidase activity in the microsomal fraction of rat liver during postnatal development. Eur. J. Biochem. 252 (1998) 178-183
127. Matysiak-Budnik T., Candalh C., Dugave C., Namane A., Cellier C., Cerf-Bensussan N., and Heyman M. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology 125 (2003) 696-707
128. Matysiak-Budnik T., Candalh C., Cellier C., Dugave C., Namane A., Vidal-Martinez T., Cerf-Bensussan N., and Heyman M. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology 129 (2005) 786-796
129. Mazurek M.F., Beal M.F., Bird E.D., and Martin J.B. Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations. Ann. Neurol. 20 (1986) 665-670
130. Mendez M., Cruz C., Joseph-Bravo P., Wilk S., and Charli J.L. Evaluation of the role of prolyl endopeptidase and pyroglutamyl peptidase I in the metabolism of LHRH and TRH in brain. Neuropeptides 17 (1990) 55-62
131. Michael-Titus A.T., Fernandes K., Setty H., and Whelpton R. In vivo metabolism and clearance of substance P and co-expressed tachykinins in rat striatum. Neuroscience 110 (2002) 277-286
132. Mitchell B.F., and Chibbar R. Synthesis and metabolism of oxytocin in late gestation in human decidua. Adv. Exp. Med. Biol. 395 (1995) 365-380
133. Mitchell B.F., Fang X., and Wong S. Metabolism of oxytocin in rat uterus and placenta in late gestation. Biol. Reprod. 57 (1997) 807-812
134. Miura N., Shibata S., and Watanabe S. Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats. Neurosci. Lett. 196 (1995) 128-130
135. Miura N., Shibata S., and Watanabe S. Z-321, a prolyl endopeptidase inhibitor, augments the potentiation of synaptic transmission in rat hippocampal slices. Behav. Brain Res. 83 (1997) 213-216
136. Mizutani S., Sumi S., Oka K., Yamada R., Kurauchi O., Taira H., Narita O., and Tomoda Y. In vitro degradation of oxytocin by pregnancy serum, placental subcellular fractions and purified placental aminopeptidases. Exp. Clin. Endocrinol. 86 (1985) 310-316
137. Mizutani S., Yokosawa H., and Tomoda Y. Degradation of oxytocin by the human placenta: effect of selective inhibitors. Acta. Endocrinol. (Copenh). 127 (1992) 76-80
138. Mizutani S., Safwat M.A., Goto K., Tsujimoto M., Nakazato H., Itakura A., Mizuno M., Kurauchi O., Kikkawa F., and Tomoda Y. Initiating and responsible enzyme of arginine vasopressin degradation in human placenta and pregnancy serum. Regul. Pept. 59 (1995) 371-378
139. Morain P., Lestage P., De Nanteuil G., Jochemsen R., Robin J.L., Guez D., and Boyer P.A. S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies. CNS. Drug. Rev. 8 (2002) 31-52
140. Mu X., Fu X., Sun H., Beremand P.D., Thomas T.L., and Klein W.H. A gene network downstream of transcription factor Math5 regulates retinal progenitor cell competence and ganglion cell fate. Dev. Biol. 280 (2005) 467-481
141. Nemeroff C.B., Kizer J.S., Reynolds G.P., and Bissette G. Neuropeptides in Alzheimer's disease: a postmortem study. Regul. Pept. 25 (1989) 123-130
142. Odaka C., Mizuochi T., Shirasawa T., Morain P., and Checler F. Murine T cells expressing high activity of prolyl endopeptidase are susceptible to activation-induced cell death. FEBS. Lett. 512 (2002) 163-167
143. Ohta N., Takahashi T., Mori T., Park M.K., Kawashima S., Takahashi K., and Kobayashi H. Hormonal modulation of prolyl endopeptidase and dipeptidyl peptidase IV activities in the mouse uterus and ovary. Acta. Endocrinol. (Copenh) 127 (1992) 262-266
144. Ohtsuki S., Homma K., Kurata S., Komano H., and Natori S. A prolyl endopeptidase of Sarcophaga peregrina (flesh fly): its purification and suggestion for its participation in the differentiation of the imaginal discs. J. Biochem. (Tokyo) 115 (1994) 449-453
145. Ohtuski S., Homma K., Kurata S., and Natori S. Nuclear localization and involvement in DNA synthesis of Sarcophaga prolyl endopeptidase. J. Biochem. (Tokyo) 121 (1997) 1176-1181
146. Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S., Saga Y., Nagase T., Ohara O., and Koga H. Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries. DNA Res. 10 (2003) 167-180
147. O'Leary R.M., and O'Connor B. Identification and localisation of a synaptosomal membrane prolyl endopeptidase from bovine brain. Eur. J. Biochem. 227 (1995) 277-283
148. O'Leary R.M., Gallagher S.P., and O'Connor B. Purification and characterization of a novel membrane-bound form of prolyl endopeptidase from bovine brain. Int. J. Biochem. Cell. Biol. 28 (1996) 441-449
149. Oliveira V., Campos M., Hemerly J.P., Ferro E.S., Camargo A.C., Juliano M.A., and Juliano L. Selective neurotensin-derived internally quenched fluorogenic substrates for neurolysin (EC 3.4.24.16): comparison with thimet oligopeptidase (EC 3.4.24.15) and neprilysin (EC 3.4.24.11). Anal. Biochem. 292 (2001) 257-265
150. Orlowski M., Wilk E., Pearce S., and Wilk S. Purification and properties of a prolyl endopeptidase from rabbit brain. J. Neurochem. 33 (1979) 461-469
151. Parvari R., Brodyansky I., Elpeleg O., Moses S., Landau D., and Hershkovitz E. A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease. Am. J. Hum. Genet. 69 (2001) 869-875
152. Paula R.D., Lima C.V., Khosla M.C., and Santos R.A. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 26 (1995) 1154-1159
153. Pepperell, J.R., Nemeth, G., Yamada, Y., Naftolin, F., Merino, M., 2006. Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells, and effects on steroidogenesis. Am. J. Physiol. Endocrinol. Metab.
154. Polgár L. pH-dependent mechanism in the catalysis of prolyl endopeptidase from pig muscle. Eur. J. Biochem. 197 (1991) 441-447
155. Polgár L. Prolyl endopeptidase catalysis. A physical rather than a chemical step is rate-limiting. Biochem. J. 283 Pt 3 (1992) 647-648
156. Polgár L. The prolyl oligopeptidase family. Cell. Mol. Life. Sci. 59 (2002) 349-362
157. Polgár L., and Patthy A. Cleavage of the Lys196-Ser197 bond of prolyl oligopeptidase: enhanced catalytic activity for one of the two active enzyme forms. Biochemistry 31 (1992) 10769-10773
158. Polgár L., Kollt E., and Hollosi M. Prolyl oligopeptidase catalysis. Reactions with thiono substrates reveal substrate-induced conformational change to be the rate-limiting step. FEBS. Lett. 322 (1993) 227-230
159. Porsti I., Bara A.T., Busse R., and Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br. J. Pharmacol. 111 (1994) 652-654
160. Potaman V.N., Alfeeva L.Y., Kamensky A.A., and Nezavibatko V.N. Degradation of ACTH/MSH(4-10) and its synthetic analog semax by rat serum enzymes: an inhibitor study. Peptides 14 (1993) 491-495
161. Puttonen, K.A., Lehtonen, S., Raasmaja, A., Mannisto, P.T., 2006. A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine. Toxicol. In Vitro, doi:10.1016/j.tiv.2006.07.001.
162. Pyle G.G., Paaso B., Anderson B.E., Allen D., Marti T., Khosla C., and Gray G.M. Low-dose gluten challenge in celiac sprue: malabsorptive and antibody responses. Clin. Gastroenterol. Hepatol. 3 (2005) 679-686
163. Pyle G.G., Paaso B., Anderson B.E., Allen D.D., Marti T., Li Q., Siegel M., Khosla C., and Gray G.M. Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue. Clin. Gastroenterol. Hepatol. 3 (2005) 687-694
164. Rampon C., Jiang C.H., Dong H., Tang Y.P., Lockhart D.J., Schultz P.G., Tsien J.Z., and Hu Y. Effects of environmental enrichment on gene expression in the brain. Proc. Natl. Acad. Sci. USA 97 (2000) 12880-12884
165. Rawlings N.D., Polgár L., and Barrett A.J. A new family of serine-type peptidases related to prolyl oligopeptidase. Biochem. J. 279 Pt 3 (1991) 907-908
166. Re R.N., and Cook J.L. The intracrine hypothesis: an update. Regul. Pept. 133 1-3 (2006) 1-9
167. Rennex D., Hemmings B.A., Hofsteenge J., and Stone S.R. cDNA cloning of porcine brain prolyl endopeptidase and identification of the active-site seryl residue. Biochemistry 30 (1991) 2195-2203
168. Robinson K.A., Bartley D.A., Robb F.T., and Schreier H.J. A gene from the hyperthermophile Pyrococcus furiosus whose deduced product is homologous to members of the prolyl oligopeptidase family of proteases. Gene 152 (1995) 103-106
169. Rosen J., Tomkinson B., Pettersson G., and Zetterqvist O. A human serine endopeptidase, purified with respect to activity against a peptide with phosphoserine in the P1′ position, is apparently identical with prolyl endopeptidase. J. Biol. Chem. 266 (1991) 3824-3834
170. Rosenblum J.S., and Kozarich J.W. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr. Opin. Chem. Biol. 7 (2003) 496-504
171. Rossner S., Schulz I., Zeitschel U., Schliebs R., Bigl V., and Demuth H.U. Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer's disease. Neurochem. Res. 30 (2005) 695-702
172. Saito M., Hashimoto M., Kawaguchi N., Shibata H., Fukami H., Tanaka T., and Higuchi N. Synthesis and inhibitory activity of acyl-peptidyl-pyrrolidine derivatives toward post-proline cleaving enzyme; a study of subsite specificity. J. Enzyme. Inhib. 5 (1991) 51-75
173. Sakaguchi M., Koseki M., Wakamatsu M., and Matsumura E. Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice. Eur. J. Pharmacol. 530 (2006) 81-87
174. Salers P., Ouafik L.H., Giraud P., Dutour A., Maltese J.Y., and Oliver C. Evidence for pyroglutamyl peptidase I and prolyl endopeptidase activities in the rat insulinoma cell line RINm 5F: lack of relationship with TRH metabolism. Mol. Cell. Biochem. 106 (1991) 15-24
175. Salers P., Ouafik L.H., Giraud P., Maltese J.Y., Dutour A., and Oliver C. Ontogeny of prolyl endopeptidase, pyroglutamyl peptidase I, TRH, and its metabolites in rat pancreas. Am. J. Physiol. 262 (1992) E845-E850
176. Santos R.A., Brosnihan K.B., Chappell M.C., Pesquero J., Chernicky C.L., Greene L.J., and Ferrario C.M. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension 11 (1988) I153-I157
177. Santos R.A., Brosnihan K.B., Jacobsen D.W., DiCorleto P.E., and Ferrario C.M. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension 19 (1992) II56-II61
178. Schneider J.S., Giardiniere M., and Morain P. Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys. Neuropsychopharmacology 26 (2002) 176-182
179. Schonlein C., Heins J., and Barth A. Purification and characterization of prolyl endopeptidase from pig brain. Biol. Chem. Hoppe. Seyler. 371 (1990) 1159-1164
180. Schulz I., Gerhartz B., Neubauer A., Holloschi A., Heiser U., Hafner M., and Demuth H.U. Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur. J. Biochem. 269 (2002) 5813-5820
181. Schulz I., Zeitschel U., Rudolph T., Ruiz-Carrillo D., Rahfeld J.U., Gerhartz B., Bigl V., Demuth H.U., and Rossner S. Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion. J. Neurochem. 94 (2005) 970-979
182. Shan L., Molberg O., Parrot I., Hausch F., Filiz F., Gray G.M., Sollid L.M., and Khosla C. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002) 2275-2279
183. Shan L., Marti T., Sollid L.M., Gray G.M., and Khosla C. Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue. Biochem. J. 383 (2004) 311-318
184. Shan L., Mathews II., and Khosla C. Structural and mechanistic analysis of two prolyl endopeptidases: role of interdomain dynamics in catalysis and specificity. Proc. Natl. Acad. Sci. USA 102 (2005) 3599-3604
185. Shariat-Madar Z., Mahdi F., and Schmaier A.H. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J. Biol. Chem. 277 (2002) 17962-17969
186. Shinoda M., Okamiya K., and Toide K. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on thyrotropin-releasing hormone-like immunoreactivity in the cerebral cortex and hippocampus of aged rats. Jpn. J. Pharmacol. 69 (1995) 273-276
187. Shinoda M., Matsuo A., and Toide K. Pharmacological studies of a novel prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion. Eur. J. Pharmacol. 305 (1996) 31-38
188. Shinoda M., Miyazaki A., and Toide K. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis magnocellularis. Behav. Brain Res. 99 (1999) 17-25
189. Shirasawa Y., Osawa T., and Hirashima A. Molecular cloning and characterization of prolyl endopeptidase from human T cells. J. Biochem. (Tokyo) 115 (1994) 724-729
190. Shishido Y., Furushiro M., Tanabe S., Shibata S., Hashimoto S., and Yokokura T. Effects of prolyl endopeptidase inhibitors and neuropeptides on delayed neuronal death in rats. Eur. J. Pharmacol. 372 (1999) 135-142
191. Shishido Y., Tanaka T., Tanabe S., Furushiro M., Hashimoto S., Yokokura T., Shibata S., and Watanabe S. ZTTA, a prolyl endopeptidase inhibitor, potentiates the arginine-vasopressin-induced incorporation of [14C]leucine in rat amygdaloid and cortical slices. Pharm. Res. 16 (1999) 463-465
192. Smith A.I., Tetaz T., Roberts J.L., Glucksman M., Clarke I.J., and Lew R.A. The role of EC 3.4.24.15 in the post-secretory regulation of peptide signals. Biochimie 76 (1994) 288-294
193. Smith A.I., Shrimpton C.N., Norman U.M., Clarke I.J., Wolfson A.J., and Lew R.A. Neuropeptidases regulating gonadal function. Biochem. Soc. Trans. 28 (2000) 430-434
194. Soeda S., Yamakawa N., Ohyama M., Shimeno H., and Nagamatsu A. An inhibitor of proline endopeptidase: purification from rat brain and characterization. Chem. Pharm. Bull. (Tokyo) 33 (1985) 24445-24451
195. Soeda S., Yamakawa N., Shimeno H., and Nagamatsu A. Effects of polyamines on proline endopeptidase activity in rat brain. J. Neurochem. 46 (1986) 1304-1307
196. Stanziola L., Greene L.J., and Santos R.A. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats. Am. J. Hypertens. 12 (1999) 1021-1029
197. Szeltner Z., Renner V., and Polgár L. Substrate- and pH-dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family. Protein. Sci. 9 (2000) 353-360
198. Szeltner Z., Rea D., Juhasz T., Renner V., Mucsi Z., Orosz G., Fülöp V., and Polgár L. Substrate-dependent competency of the catalytic triad of prolyl oligopeptidase. J. Biol. Chem. 277 (2002) 44597-44605
199. Szeltner Z., Rea D., Juhasz T., Renner V., Fülöp V., and Polgár L. Concerted structural changes in the peptidase and the propeller domains of prolyl oligopeptidase are required for substrate binding. J. Mol. Biol. 340 (2004) 627-637
200. Szeltner Z., Alshafee I., Juhasz T., Parvari R., and Polgár L. The PREPL A protein, a new member of the prolyl oligopeptidase family, lacking catalytic activity. Cell. Mol. Life. Sci. 62 (2005) 2376-2381
201. Taylor W.L., and Dixon J.E. Catabolism of neuropeptides by a brain proline endopeptidase. Biochem. Biophys. Res. Commun. 94 (1980) 9-15
202. Taylor W.L., Andrews P.C., Henrikson C.K., and Dixon J.E. New fluorogenic substrates for a rat brain proline endopeptidase. Anal. Biochem. 105 (1980) 58-64
203. Terwel D., Bothmer J., Wolf E., Meng F., and Jolles J. Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia. J. Neurol. Sci. 161 (1998) 47-56
204. Toide K., Iwamoto Y., Fujiwara T., and Abe H. JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer. J. Pharmacol. Exp. Ther. 274 (1995) 1370-1378
205. Toide K., Okamiya K., Iwamoto Y., and Kato T. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on prolyl endopeptidase activity and substance P- and arginine-vasopressin-like immunoreactivity in the brains of aged rats. J. Neurochem. 65 (1995) 234-240
206. Toide K., Fujiwara T., Iwamoto Y., Shinoda M., Okamiya K., and Kato T. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain. Naunyn. Schmiedebergs. Arch. Pharmacol. 353 (1996) 355-362
207. Toide K., Shinoda M., Fujiwara T., and Iwamoto Y. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats. Pharmacol. Biochem. Behav. 56 (1997) 427-434
208. Toide K., Shinoda M., Iwamoto Y., Fujiwara T., Okamiya K., and Uemura A. A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer's disease. Behav. Brain Res. 83 (1997) 147-151
209. Tsukahara T., Ishiura S., and Sugita H. Regulation of prolyl endopeptidase activity by the intracellular redox state. J. Biol. Chem. 265 (1990) 21448-21453
210. Valdivia A., Irazusta J., Fernandez D., Mugica J., Ochoa C., and Casis L. Pyroglutamyl peptidase I and prolyl endopeptidase in human semen: increased activity in necrozoospermia. Regul. Pept. 122 (2004) 79-84
211. Vanhoof G., Goossens F., Hendriks L., De Meester I., Hendriks D., Vriend G., Van Broeckhoven C., and Scharpe S. Cloning and sequence analysis of the gene encoding human lymphocyte prolyl endopeptidase. Gene 149 (1994) 363-366
212. Venäläinen J.I., Juvonen R.O., and Männistö P.T. Evolutionary relationships of the prolyl oligopeptidase family enzymes. Eur. J. Biochem. 271 (2004) 2705-2715
213. Venäläinen J.I., García-Horsman J.A., Forsberg M.M., Jalkanen A., Wallén E.A., Jarho E.M., Christiaans J.A., Gynther J., and Männistö P.T. Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors. Biochem. Pharmacol. 71 (2006) 683-692
214. Vendite D., Dalmaz C., Netto C.A., and Rocha J.B. Undernutrition during suckling does not change the specific or total activity of hypothalamic proline endopeptidase in adult rats. Braz. J. Med. Biol. Res. 22 (1989) 1475-1477
215. Wallén E.A., Christiaans J.A., Forsberg M.M., Venäläinen J.I., Männistö P.T., and Gynther J. Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors. J. Med. Chem. 45 (2002) 4581-4584
216. Wallén E.A., Christiaans J.A., Saario S.M., Forsberg M.M., Venäläinen J.I., Paso H.M., Männistö P.T., and Gynther J. 4-Phenylbutanoyl-2(S)-acylpyrrolidines and 4-phenylbutanoyl-L-prolyl-2(S)-acylpyrrolidines as prolyl oligopeptidase inhibitors. Bioorg. Med. Chem. 10 (2002) 2199-2206
217. Wallén E.A., Christiaans J.A., Saarinen T.J., Jarho E.M., Forsberg M.M., Venäläinen J.I., Männistö P.T., and Gynther J. Conformationally rigid N-acyl-5-alkyl-L-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors. Bioorg. Med. Chem. 11 (2003) 3611-3619
218. Wallén, E.A., 2003. Design and synthesis of novel prolyl oligopeptidase inhibitors. Department of Pharmaceutical Chemistry. Kuopio, University of Kuopi.
219. Walter R. Partial purification and characterization of post-proline cleaving enzyme: enzymatic inactivation of neurohypophyseal hormones by kidney preparations of various species. Biochim. Biophys. Acta. 422 (1976) 138-158
220. Walter R., Shlank H., Glass J.D., Schwartz I.L., and Kerenyi T.D. Leucylglycinamide released from oxytocin by human uterine enzyme. Science 173 (1971) 827-829
221. Welches W.R., Santos R.A., Chappell M.C., Brosnihan K.B., Greene L.J., and Ferrario C.M. Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J. Hypertens. 9 (1991) 631-638
222. Welches W.R., Brosnihan K.B., and Ferrario C.M. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci. 52 (1993) 1461-1480
223. de Wied D., Gaffori O., van Ree J.M., and de Jong W. Central target for the behavioural effects of vasopressin neuropeptides. Nature 308 (1984) 276-278
224. Wilk S. Prolyl endopeptidase. Life Sci. 33 (1983) 2149-2157
225. Wilk S., and Orlowski M. Inhibition of rabbit brain prolyl endopeptidase by n-benzyloxycarbonyl-prolyl-prolinal, a transition state aldehyde inhibitor. J. Neurochem. 41 (1983) 69-75
226. Wilk S., Benuck M., Orlowski M., and Marks N. Degradation of luteinizing hormone-releasing hormone (LHRH) by brain prolyl endopeptidase with release of des-glycinamide LHRH and glycinamide. Neurosci. Lett. 14 (1979) 275-279
227. Williams R.S., and Harwood A.J. Lithium therapy and signal transduction. Trends Pharmacol. Sci. 21 (2000) 61-64
228. Williams R.S., Eames M., Ryves W.J., Viggars J., and Harwood A.J. Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J. 18 (1999) 2734-2745
229. Williams R.S., Cheng L., Mudge A.W., and Harwood A.J. A common mechanism of action for three mood-stabilizing drugs. Nature 417 (2002) 292-295
230. Xie H.X., Nie P., and Sun B.J. Characterization of two membrane-associated protease genes obtained from screening out-membrane protein genes of Flavobacterium columnare G4. J. Fish. Dis. 27 (2004) 719-729
231. Yamakawa N., Shimeno H., Soeda S., and Nagamatsu A. Regulation of prolyl oligopeptidase activity in regenerating rat liver. Biochim. Biophys. Acta. 1199 (1994) 279-284
232. Yamanaka C., Lebrethon M.C., Vandersmissen E., Gerard A., Purnelle G., Lemaitre M., Wilk S., and Bourguignon J.P. Early prepubertal ontogeny of pulsatile gonadotropin-releasing hormone (GnRH) secretion: I. Inhibitory autofeedback control through prolyl endopeptidase degradation of GnRH. Endocrinology 140 (1999) 4609-4615
233. Yanagisawa T., Prasad C., and Peterkofsky A. The subcellular and organ distribution and natural form of histidyl-proline diketopiperazine in rat brain determined by a specific radioimmunoassay. J. Biol. Chem. 255 (1980) 10290-10294
234. Yang Z., Zhang F., Zhu L., and He G. Identification of differentially expressed genes in brown planthopper Nilaparvata lugens (Hemiptera: Delphacidae) responding to host plant resistance. Bull. Entomol. Res. 96 (2006) 53-59
235. Yasuda Y., Mizutani S., Kurauchi O., Kasugai M., Narita O., and Tomoda Y. Induction by cortisol of aminopeptidases production from the human placenta in tissue culture. Horm. Metab. Res. 24 (1992) 110-114
236. Yoshimoto T., Ogita K., Walter R., Koida M., and Tsuru D. Post-proline cleaving enzyme. Synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluids of man. Biochim. Biophys. Acta. 569 (1979) 184-192
237. Yoshimoto T., Simmons W.H., Kita T., and Tsuru D. Post-proline cleaving enzyme from lamb brain. J. Biochem. (Tokyo) 90 (1981) 325-334
238. Yoshimoto T., Tsukumo K., Takatsuka N., and Tsuru D. An inhibitor for post-proline cleaving enzyme; distribution and partial purification from porcine pancreas. J. Pharmacobiodyn. 5 (1982) 734-740
239. Yoshimoto T., Nishimura T., Kita T., and Tsuru D. Post-proline cleaving enzyme (prolyl endopeptidase) from bovine brain. J. Biochem. (Tokyo) 94 (1983) 1179-1190
240. Yoshimoto T., Kado K., Matsubara F., Koriyama N., Kaneto H., and Tsura D. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect. J. Pharmacobiodyn. 10 (1987) 730-735
241. Yoshimoto T., Sattar A.K., Hirose W., and Tsuru D. Studies on prolyl endopeptidase from shakashimeji (Lyophyllum cinerascens): purification and enzymatic properties. J. Biochem. (Tokyo) 104 (1988) 622-627
242. Yoshimoto T., Kanatani A., Shimoda T., Inaoka T., Kokubo T., and Tsuru D. Prolyl endopeptidase from Flavobacterium meningosepticum: cloning and sequencing of the enzyme gene. J. Biochem. (Tokyo) 110 (1991) 873-878
243. Yoshimoto T., Miyazaki K., Haraguchi N., Kitazono A., Kabashima T., and Ito K. Cloning and expression of the cDNA encoding prolyl oligopeptidase (prolyl endopeptidase) from bovine brain. Biol. Pharm. Bull. 20 (1997) 1047-1050
244. Zolfaghari R., Baker C.R., Canizaro P.C., Feola M., Amirgholami A., and Behal F.J. Human lung post-proline endopeptidase: purification and action on vasoactive peptides. Enzyme 36 (1986) 165-178